65 related articles for article (PubMed ID: 17481885)
1. Proteomic co-expression of cyclin-dependent kinases 1 and 4 in human cancer cells.
Seabra L; Warenius H
Eur J Cancer; 2007 Jun; 43(9):1483-92. PubMed ID: 17481885
[TBL] [Abstract][Full Text] [Related]
2. Dynamic heterogeneity of proteomic expression in human cancer cells does not affect Cdk1/Cdk4 co-expression.
Warenius H; Howarth A; Seabra L; Kyritsi L; Dormer R; Anandappa S; Thomas C
J Exp Ther Oncol; 2008; 7(3):237-54. PubMed ID: 19066132
[TBL] [Abstract][Full Text] [Related]
3. Expression and activity of cell cycle-regulatory proteins in normal and transformed corneal endothelial cells.
Schönthal AH; Hwang JJ; Stevenson D; Trousdale MD
Exp Eye Res; 1999 May; 68(5):531-9. PubMed ID: 10328966
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous regression of human cancer cells in vitro: potential role of disruption of Cdk1/Cdk4 co-expression.
Warenius H; Kyritsi L; Grierson I; Howarth A; Seabra L; Jones M; Thomas C; Browning P; White R
Anticancer Res; 2009 Jun; 29(6):1933-41. PubMed ID: 19528450
[TBL] [Abstract][Full Text] [Related]
5. Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells.
Van Dross R; Yao S; Asad S; Westlake G; Mays DJ; Barquero L; Duell S; Pietenpol JA; Browning PJ
J Natl Cancer Inst; 2005 May; 97(9):656-66. PubMed ID: 15870436
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
7. Differential cyclin-dependent kinase expression and activation in human colon cancer.
Salh B; Bergman D; Marotta A; Pelech SL
Anticancer Res; 1999; 19(1B):741-8. PubMed ID: 10216486
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathology of the cell cycle in human cancer cells.
Bártek J; Stasková Z; Draetta G; Lukás J
Stem Cells; 1993 May; 11 Suppl 1():51-8. PubMed ID: 8318919
[TBL] [Abstract][Full Text] [Related]
9. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
[TBL] [Abstract][Full Text] [Related]
10. Selective anticancer activity of a hexapeptide with sequence homology to a non-kinase domain of Cyclin Dependent Kinase 4.
Warenius HM; Kilburn JD; Essex JW; Maurer RI; Blaydes JP; Agarwala U; Seabra LA
Mol Cancer; 2011 Jun; 10():72. PubMed ID: 21668989
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression.
Tam SW; Theodoras AM; Shay JW; Draetta GF; Pagano M
Oncogene; 1994 Sep; 9(9):2663-74. PubMed ID: 8058330
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
J Cell Physiol; ; . PubMed ID: 7593219
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
